ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
18 hedge funds and large institutions have $32.5M invested in Anebulo Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.06% less ownership
Funds ownership: 55.05% → 54.99% (-0.06%)
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$15.8K | |
| 2 | +$13.1K | |
| 3 | +$13K | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$1.74K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$344 |
Top Sellers
| 1 | -$41.5K | |
| 2 | -$30K | |
| 3 | -$5.88K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$326 |
| 5 |
JP Morgan Chase
New York
|
-$10 |